Tiratricol
| Clinical data | |
|---|---|
| Other names | 3,3',5-triiodothyroacetic acid TRIAC |
| AHFS/Drugs.com | International Drug Names |
| Drug class | Thyroid hormone |
| ATC code | |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Metabolism | Liver glucuronidation |
| Excretion | Bile duct |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.000.079 |
| Chemical and physical data | |
| Formula | C14H9I3O4 |
| Molar mass | 621.935 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| (what is this?) (verify) | |
Tiratricol (also known as TRIAC or triiodothyroacetic acid) is a thyroid hormone analogue. Triiodothyroacetic acid is also a physiologic thyroid hormone that is present in the normal organism in low concentrations. Tiratricol is an analogue of a naturally circulating metabolite of the active thyroid hormone T3. MCT8 is a specific thyroid hormone transporter. While T3 and T4 thyroid hormones rely on MCT8 to enter several tissues such as the brain, tiratricol can enter cells independently of MCT8. Once inside cells, tiratricol activates the thyroid hormone receptor in a similar way to endogenous T3.
The most common side effects are excessive sweating, irritability, anxiety and nightmares.